Skip to main content
CHC logo

CHC — Investor Relations & Filings

Ticker · 4164 ISIN · TW0004164009 TW Wholesale and retail trade
Open in API
Filings indexed 2,275 across all filing types
Latest filing 2017-05-08 Director's Dealing
Country TW Taiwan
Listing TW 4164

About CHC

www.chcg.com

CHC Healthcare Group is a provider of comprehensive medical equipment, technology, and management services. The company offers one-stop solutions ranging from equipment distribution and leasing to operational consulting and hospital management. Its extensive portfolio covers specialized fields such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, dentistry, and rehabilitation. Representing over 30 international brands, the group is a major distributor of high-end medical devices and a leader in oncology equipment. Beyond equipment sales and maintenance, the company has expanded into long-term care, radiation sterilization services, and chain pharmacy channels. With a focus on smart healthcare and advanced medical technologies, the group supports healthcare providers through technical maintenance, personnel training, and integrated department construction across the Asia-Pacific region.

Recent filings

Filing Released Lang Actions
106年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It focuses on internal shareholding disclosures and insider relationships, with no financial statements, earnings data, or management discussion. The content is about insider shareholdings and pledges, which aligns with reporting on personal share transactions or holdings by company directors and executives. There is no indication of a full annual report, earnings release, or other financial report. The document is not a brief announcement but a detailed insider shareholding disclosure. Therefore, the most appropriate classification is Director's Dealing (DIRS). The document length is 2815 characters, which is consistent with a detailed insider shareholding report rather than a short announcement or a full financial report.
2017-05-08 Chinese
106年04月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings and changes in share ownership by insiders, including directors, supervisors, and senior management. It includes data on shares held, increases, decreases, and trust shares, with specific references to identities and roles such as chairman, directors, independent directors, supervisors, general manager, deputy general managers, financial and accounting department heads. The content is focused on insider shareholdings and transactions rather than financial results, management discussion, or corporate governance policies. There is no indication of an annual report, earnings release, or other financial report. The document is not a proxy statement or voting results announcement. It is a detailed insider shareholding disclosure, which corresponds to Director's Dealing filings reporting personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2017-05-08 Chinese
106年5月2日內部人設質解質
Director's Dealing Classification · 95% confidence The document contains a table listing share pledge information involving a company director (董事長本人) and details about pledged shares (質設股數), dates, and pledgees. This type of disclosure relates to personal share transactions or dealings by company directors or executives. There is no indication of financial results, reports, or announcements of meetings. The content fits the definition of Director's Dealing (DIRS). The document is short and factual, consistent with insider share transaction reporting.
2017-05-03 Chinese
本公司董事會通過重要子公司久和醫療儀器(股)公司自地委建案
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (4164 承業醫) regarding the approval of a contract by its board for a subsidiary's construction project. It includes details about the contract type, parties involved, contract amounts, and other related information. The document is short (1061 characters) and does not contain financial statements or detailed financial analysis. It is an announcement of a corporate transaction rather than a financial report or management discussion. It fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about a corporate contract and does not match other more specific categories like Capital/Financing Update or M&A Activity.
2017-05-02 Chinese
本公司資金貸與餘額達「公開發行公司資金貸與及背書保證處理準 則」第二十二條第一項第三款之公告標準
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a publicly listed company (4164 承業醫) disclosing details about funds lent to subsidiaries, including amounts, relationships, interest rates, repayment terms, and financial ratios. It references compliance with a specific regulatory standard for public companies regarding fund lending and guarantees. The document is relatively short (2919 characters) and is a factual disclosure rather than a financial report or detailed analysis. It does not contain financial statements or management discussion but is a compliance announcement about capital lending activities. This fits the category of Capital/Financing Update (CAP), which covers updates on company financing activities or capital structure changes.
2017-05-02 Chinese
公告本公司提報董事會民國106年第一季合併財務報告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company (承業生醫投資控股股份有限公司) reporting the submission of its consolidated financial report for the first quarter of the year 106 (Taiwan calendar, equivalent to 2017). It includes key financial figures such as net revenue, operating profit, net profit, and earnings per share. The document is short (777 characters) and primarily serves as a notification that the quarterly financial report has been submitted to the board. It does not contain the full financial statements or detailed analysis itself, but rather announces the filing of the interim/quarterly report. According to the 'Menu vs Meal' rule, such announcements are typically classified as Regulatory Filings (RNS) unless the full report is included. Since this document is brief and only announces the report submission, the appropriate classification is Regulatory Filings (RNS).
2017-05-02 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.